Literature DB >> 6549535

Histopathology of the spinal cord after intrathecal cocaine, bupivacaine, lignocaine and adrenaline in the rat.

M Bahar, G Cole, M Rosen, M D Vickers.   

Abstract

Repeated intrathecal injections were given through catheters which had been chronically implanted in the subarachnoid space of rats. Injections were made of cocaine 0.25%, 0.125% and 0.0625%; bupivacaine 0.5%; lignocaine 2% and 0.5%; adrenaline 0.01% (1 in 10 000) and 0.002% (1 in 200 000); and sodium chloride 0.9%. Five injections of 35 microliter of each concentration of each drug were given hourly each day for two days to three rats. No clinical nerve damage was detectable in any rat. The only pathological change found in any rat was the development of cytoplasmic vacuolation in the neurones of the anterior and posterior horns. The changes were most prominent after injection of 0.9% sodium chloride and bupivacaine, whilst lignocaine (0.5 and 2%) showed the least number of vacuoles, which were also the smallest in size. Adrenaline and cocaine were intermediate in effect. There was no evidence of cell death. These changes were not seen in control animals in which catheters had been implanted but no injections had been given. The changes were mild and it is concluded that the agents tested caused no significant damage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6549535

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  3 in total

Review 1.  Cocaine use and stroke.

Authors:  Sean D Treadwell; Tom G Robinson
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

Review 2.  [Damages to the central nervous system due to illicit drug use].

Authors:  A Bachhuber
Journal:  Radiologe       Date:  2018-12       Impact factor: 0.635

3.  N-acetyl cysteine mitigates the acute effects of cocaine-induced toxicity in astroglia-like cells.

Authors:  Ramesh B Badisa; Sanjay S Kumar; Elizabeth Mazzio; Rasheda D Haughbrook; John R Allen; Michael W Davidson; Cheryl A Fitch-Pye; Carl B Goodman
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.